News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Laura Bukavina: How Do We Predict Patients with True CR Using Urine Biomarkers?
Laura Bukavina/X
Jun 25, 2025, 09:08

Laura Bukavina: How Do We Predict Patients with True CR Using Urine Biomarkers?

Laura Bukavina, Urologic Oncologist at Cleveland Clinic, shared on X:

“Always chasing that pT0 state .. and how do we predict patients with true CR using urine biomarkers? Phenomenal discussion > point by point analysis of why current urine markers fail by Phil Abbosh Fox Chase Cancer Center during his U54 Robin lecture series visit Cleveland Clinic Urology.“

Laura Bukavina

 

cancer Cleveland Clinic Laura Bukavina OncoDaily Oncology
Special Coverage
Voices
Aug 25, 2025, 14:49
The Future of Cancer Care is About Supporting Patients Through Innovation - SPCC
Voices
Aug 25, 2025, 14:44
Miriam Mutebi: So, Here’s Why Basic and Translational Research Is Important
Voices
Aug 25, 2025, 14:42
Gustavo Viani: A Game Changer in Cervical Cancer RT?
Insight
Aug 25, 2025, 14:34
Philipp Ivanyi Highlights Need for Reconsideration in Cancer Treatment Landscape
Voices
Aug 25, 2025, 14:32
Douglas Flora: America Is Abandoning One of the Greatest Medical Breakthroughs
Insight
Aug 25, 2025, 14:21
Anirban Maitra Highlights New Paper on Therapeutic Targets for Pancreatic Cancer
OncoDaily Pulse
Aug 25, 2025, 14:16
Padraic O’Malley: Meet the Experts of VIRO 2025
Insight
Aug 25, 2025, 14:15
Hidden Risks: BRCA Mutations and Breast Implants - CancerWorld
Voices
Aug 25, 2025, 13:49
Mario I Fernandez: Joining LATAM Bladder Cancer Experts at the IBCG in Houston
Voices
Aug 25, 2025, 13:34
Gevorg Tamamyan: Hemostasis Today - A New Era in Hemostasis and Thrombosis Reporting
Career Updates
Aug 25, 2025, 13:16
Jouliana Sadek Joins the Kyowa Kirin North America Team as Associate Director, Medical Value Outcomes Liaison
FDA Approvals
Aug 25, 2025, 13:00
FDA Breakthrough Therapy Designation for Iza-bren: Advancing Treatment for EGFR-Mutant NSCLC